このページの翻訳は実験的なもので、現在開発中です。お待ちしております！

Arjo 将来の成長

Future 基準チェック /46

Arjo利益と収益がそれぞれ年間21.4%と3.8%増加すると予測されています。EPS は年間増加すると予想されています。自己資本利益率は 3 年後に9.9% 21.4%なると予測されています。

主要情報

20.9%

収益成長率

20.9%

EPS成長率

Medical Equipment 収益成長	22.2%
収益成長率	3.8%
将来の株主資本利益率	9.8%
アナリストカバレッジ	Low
最終更新日	26 Jun 2024

今後の成長に関する最新情報

Recent updates

業績と収益の成長予測

BATS-CHIXE:ARJOBS - アナリストの将来予測と過去の財務データ ( )SEK Millions
日付	収益	収益	フリー・キャッシュフロー	営業活動によるキャッシュ	平均アナリスト数
12/31/2026	12,356	896	1,153	1,848	4
12/31/2025	11,894	774	1,042	1,714	5
12/31/2024	11,408	620	931	1,505	5
3/31/2024	11,101	499	1,428	2,067	N/A
12/31/2023	10,980	480	1,382	2,061	N/A
9/30/2023	10,787	408	1,074	1,739	N/A
6/30/2023	10,529	396	695	1,421	N/A
3/31/2023	10,247	398	245	1,052	N/A
12/31/2022	9,979	449	16	827	N/A
9/30/2022	9,749	544	198	1,103	N/A
6/30/2022	9,477	648	362	1,213	N/A
3/31/2022	9,272	733	661	1,484	N/A
12/31/2021	9,070	742	974	1,734	N/A
9/30/2021	9,012	727	1,167	1,938	N/A
6/30/2021	8,908	669	1,261	2,073	N/A
3/31/2021	8,973	594	1,497	2,255	N/A
12/31/2020	9,078	526	1,460	2,267	N/A
9/30/2020	9,156	510	1,140	1,862	N/A
6/30/2020	9,167	423	1,022	1,716	N/A
3/31/2020	9,115	408	611	1,359	N/A
12/31/2019	8,976	403	494	1,252	N/A
9/30/2019	8,807	341	375	1,148	N/A
6/30/2019	8,634	354	225	969	N/A
3/31/2019	8,408	346	188	903	N/A
12/31/2018	8,217	296	349	991	N/A
9/30/2018	7,978	131	54	832	N/A
6/30/2018	7,792	3	9	754	N/A
3/31/2018	7,700	4	16	687	N/A
12/31/2017	7,688	118	N/A	572	N/A
9/30/2017	7,794	266	N/A	593	N/A
12/31/2016	7,808	490	N/A	919	N/A
12/31/2015	8,115	307	N/A	811	N/A
12/31/2014	7,568	619	N/A	959	N/A

アナリストによる今後の成長予測

収入対貯蓄率: ARJOBSの予測収益成長率 (年間21.4% ) は貯蓄率 ( 1.8% ) を上回っています。

収益対市場: ARJOBSの収益 ( 21.4% ) はUK市場 ( 13.2% ) よりも速いペースで成長すると予測されています。

高成長収益: ARJOBSの収益は今後 3 年間で大幅に増加すると予想されています。

収益対市場: ARJOBSの収益 ( 3.8% ) UK市場 ( 3.7% ) よりも速いペースで成長すると予測されています。

高い収益成長: ARJOBSの収益 ( 3.8% ) 20%よりも低い成長が予測されています。

一株当たり利益成長率予想

将来の株主資本利益率

将来のROE: ARJOBSの自己資本利益率は、3年後には低くなると予測されています ( 9.9 %)。

Arjo 将来の成長

Future 基準チェック /46

主要情報

今後の成長に関する最新情報

Arjo Provides Sales Guidance for the Year 2024

Arjo AB (Publ) Provides Financial Outlook for 2023

Arjo AB (publ) Provides Organic Sales Guidance for the Year 2023

Arjo AB (publ) Updates Sales Guidance for the Full Year 2022

Arjo AB (Publ) Provides Sales Guidance for the Year 2021

Recent updates

Arjo Provides Sales Guidance for the Year 2024

Arjo AB (publ) Approves the Election of Ulrika Dellby as New Member of the Board

Arjo AB (Publ) Proposes Dividend, Payable on 25 April 2024

Arjo AB (publ) to Report Fiscal Year 2023 Final Results on Mar 21, 2024

Arjo AB (publ) to Report Nine Months, 2024 Results on Oct 17, 2024

Less than half of directors are independent

Less than half of directors are independent

Arjo AB (Publ) Provides Financial Outlook for 2023

Arjo AB (publ) to Report Q1, 2024 Results on Apr 18, 2024

Less than half of directors are independent

Investor sentiment improves as stock rises 19%

Second quarter 2023 earnings released: EPS: kr0.37 (vs kr0.38 in 2Q 2022)

Arjo Announces Executive Changes

Less than half of directors are independent

Arjo AB (publ) Announces Resignation of Daniel Fäldt as CFO

Less than half of directors are independent

First quarter 2023 earnings released: EPS: kr0.35 (vs kr0.60 in 1Q 2022)

Less than half of directors are independent

Less than half of directors are independent

Insider recently bought kr498k worth of stock

Independent Chairman of the Board recently bought kr2.0m worth of stock

Less than half of directors are independent

Independent Chairman of the Board recently bought kr2.0m worth of stock

Arjo AB (publ) to Report Nine Months, 2023 Results on Oct 19, 2023

Full year 2022 earnings released: EPS: kr1.64 (vs kr2.72 in FY 2021)

Arjo AB (publ) Proposes Dividend for the Year 2022, Payable on April 27, 2023

Arjo AB (publ) Provides Organic Sales Guidance for the Year 2023

Less than half of directors are independent

Third quarter 2022 earnings released

Arjo AB (publ) Updates Sales Guidance for the Full Year 2022

Investor sentiment deteriorated over the past week

Less than half of directors are independent

Second quarter 2022 earnings released: EPS: kr0.38 (vs kr0.69 in 2Q 2021)

Arjo AB (publ) to Report Q1, 2023 Results on Apr 20, 2023

Less than half of directors are independent

Less than half of directors are independent

CEO, President & Director recently bought kr1.0m worth of stock

First quarter 2022 earnings released: EPS: kr0.60 (vs kr0.64 in 1Q 2021)

Less than half of directors are independent

Arjo AB (publ) Approves Dividend for the Year 2021

Chief Financial Officer recently bought kr462k worth of stock

CEO, President & Director recently bought kr5.0m worth of stock

Full year 2021 earnings: Revenues and EPS in line with analyst expectations

Arjo AB (publ) to Report First Half, 2022 Results on Jul 14, 2022

Arjo AB (Publ) Proposes Dividend for the Year 2021, Payable on April 29, 2022

Less than half of directors are independent

Independent Director recently bought kr482k worth of stock

Third quarter 2021 earnings released

Less than half of directors are independent

Less than half of directors are independent

Second quarter 2021 earnings released: EPS kr0.69 (vs kr0.42 in 2Q 2020)

Arjo AB (Publ) Resolves to Declare A Dividend

Arjo AB (Publ) Provides Sales Guidance for the Year 2021

Upcoming dividend of kr0.85 per share

Full year 2020 earnings released: EPS kr1.93 (vs kr1.48 in FY 2019)

New 90-day high: kr67.60

CEO, President & Director recently bought kr1.0m worth of stock

Full year 2020 earnings released: EPS kr1.93 (vs kr1.48 in FY 2019)

Revenue beats expectations

Arjo AB (publ) (OM:ARJO B) acquired AirPal.

Arjo AB (publ) to Report Q1, 2021 Results on Apr 27, 2021

Bruin Biometrics, LLLC and Arjo Agree Exclusive Worldwide Distribution Rights for Pressure Ulcer Sem Scanner

Arjo Enters into Distribution Agreement with Brainlit

業績と収益の成長予測

アナリストによる今後の成長予測

一株当たり利益成長率予想

将来の株主資本利益率

成長企業の発掘